---
workflow: 'bmad-testarch-trace'
mode: 'Validate'
validatedAt: '2026-08-25T11:53:25Z'
validatedTarget: 'authoring-agent-onboarding-complete'
sourceSha: '59986a81bf3d9523d6a963b5891437bdb796e0ff'
phase6ExecutionEvidenceRevision: '477c31765b7b7c7412e8461226517e6984e2bc7c'
exactFinalCandidateSha: 'c7753aa4829c758964a1c6811fc05b8d06aad4cd'
validatedArtifact: '_bmad-output/test-artifacts/traceability/trace-authoring-agent-onboarding-complete.md'
validationResult: 'PASS_WITH_WARNINGS'
coverageGateDecision: 'PASS'
integratedGateDecision: 'WAIVED'
---

# Trace Workflow Validation - Authoring Agent Onboarding Complete Initiative

## Result: **PASS WITH WARNINGS**

The final Edit-mode trace artifacts are readable, parseable, internally consistent, and faithful to the
human-disposed Phase-6 result. Artifact validation passes with the semantic and non-gating quality warnings
below. Coverage remains **PASS**. The integrated gate is **WAIVED**, not PASS: expired OAuth still prevented
all 24 required Claude behavioral subruns, and the user explicitly allowed continuation without that evidence.
No missing behavioral cell or Claude behavioral acceptance is inferred.

Every section and nested check in the installed 671-line trace checklist was evaluated. A child check inherits
its section result unless the notes identify it as N/A, WARN, or WAIVED.

## Checklist Evaluation

| Checklist section | Result | Notes |
| --- | --- | --- |
| Phase-1 prerequisites | PASS | Formal Backlog oracle, planning artifacts, test design, 21 final story/QA/review records, retrospective, current tests, NFR assessment, and retained execution evidence are available. The actual test root is `test/`, a documented deviation from generic `tests/`. |
| Context loading and oracle resolution | PASS | The authoritative oracle remains 192 final checked criteria for TASK-107..TASK-127. Planning artifacts corroborate without replacing final task wording; no external pointer is required. |
| Test discovery and cataloging | PASS | Discovery retains 67 feature-relevant files, 815 static titled declarations, 378 negative/edge signals, and 245 deduplicated mapped declarations across 45 files. |
| Criteria-to-test mapping | PASS | Exactly 192 canonical rows map every criterion to resolvable QA/source evidence. All are FULL; none is PARTIAL, NONE, UNIT-ONLY, or INTEGRATION-ONLY where another level applies. |
| Coverage classification and metrics | PASS | Overall 192/192; P0 150/150; P1 42/42; all gap classes zero. Markdown and JSON counts agree. |
| Duplicate coverage | PASS | Unit and integration/E2E overlap at filesystem, Backlog, built-CLI, package, and source-free boundaries is intentional defense in depth. |
| Gap analysis and heuristics | PASS | No acceptance, endpoint, auth-negative, happy-path-only, UI-journey, or UI-state gap exists. HTTP/login/browser checks are N/A for the local CLI. |
| Test quality verification | WARN | Principal evidence is active and deterministic with assertions, cleanup, zero skipped/pending/fixme, and no hard waits. Thirty of 67 files exceed 300 lines; exact-final suite duration is 1,879.12 seconds. No applicable threshold is breached. |
| Phase-1 Markdown deliverable | PASS | Context, catalog, 192-row matrix, coverage analysis, recommendations, quality observation, waiver decision, residual risk, and provenance are present. Scoped routing preserves unrelated history. |
| Machine-readable deliverables | PASS | Both JSON files parse and agree on target, gate/candidate/evidence/hash identities, 192/192 coverage, 17/0/0/1 NFR counts, exact-final PASS facts, 0/24 Claude execution, one waiver, zero blockers, and final WAIVED. |
| Story/status update | N/A | Prohibited. No story, Backlog, state, governance, product, or test file is changed. |
| Phase-1 accuracy and actionability | PASS | All oracle items, priorities, levels, statuses, paths, evidence identities, and present conditions remain reconciled. No trace-driven ATDD task is warranted. |
| Phase-1 documentation | PASS | Tables are readable, local paths concrete, historical and final decisions distinct, and no unsupported remote URL is invented. |
| Phase-2 evidence prerequisites | PASS | Exact candidate, stable product/test tree, cold execution, audit, package inspection, source-free install, inactive assessments, cleanup, NFR audit, retrospective, and human waiver are available. Code coverage/burn-in remain N/A, not inferred. |
| Phase-2 evidence validation | WAIVED | Exact-final cold/package evidence is complete and PASS. Claude parity remains 0/24 because OAuth 401 occurred before all cells. The user waived this sole evidence obligation; the evidence itself is not PASS. |
| Phase-2 knowledge and context | PASS | Risk governance, probability-impact, priority thresholds, test quality, selective testing, target, and waiver policy were applied. |
| Test/result parsing | PASS | Outputs retain 140/140 files, 1,944/1,944 tests, exit 0, 1,879.12 seconds, 17/0/0/1 NFR disposition, exact archive facts, and 0/24 without extrapolation. |
| Code coverage and burn-in parsing | N/A | Neither report was supplied or required; no percentage or stability result is fabricated. |
| Decision rules | WARN | Top-level workflow supports manual stakeholder WAIVED decisions, and explicit user disposition drives this result. One generic checklist scenario says waivers apply only to FAIL, while the waived source state here was CONCERNS. The user directive controls; the deviation is explicit and no PASS results. |
| Risk classification and ownership | PASS WITH WARNINGS | Former `PHASE6-B1` is now scoped waiver `PHASE6-W1`: MEDIUM residual risk, zero open blockers, NFR8, 0/24. Approver is the project human gate authority; organizational title, expiry, and calendar remediation date were not supplied and are not invented. |
| Gate documentation | PASS | Target, date, evaluator, revisions/hashes, coverage, NFRs, execution facts, exact waiver words, scope, approver, residual risk, optional remediation, prohibited inference, and false acceptance/release claims are explicit. |
| Gate YAML / notifications | N/A | Installed/configured workflow emits scoped JSON rather than gate YAML. Notifications and external delivery are disabled and unauthorized. |
| Phase-2 outputs | PASS | Scoped Markdown and both JSON outputs agree on coverage PASS, cold/package PASS, NFR WAIVED, and integrated `WAIVED_HUMAN_DISPOSITION`. |
| Decision integrity and transparency | PASS WITH WARNINGS | Decision preserves evidence facts and separates WAIVED risk disposition from behavioral proof. Checklist-policy/metadata deviations are disclosed rather than hidden. |
| CI/stakeholder integration | N/A | Gate JSON is automation-readable, but external CI, publication, notification, or delivery is outside this assignment. Human disposition is already recorded. |
| Audit/compliance | PASS WITH WARNINGS | Evaluator, timestamps, SHA identities, oracle, matrix, evidence/package hashes, 17/0/0/1 counts, exact words, scope, and residual risk are recorded. Waiver expiry and organizational title remain explicitly unspecified. |
| Missing/stale/conflicting evidence | PASS | Missing Claude evidence remains visible at 0/24. Exact-final evidence closes NFR10. No stale CONCERNS verdict, old source SHA, pending-cold state, or conflicting gate status remains. |
| Waiver rules | WARN | Business reason and human approver are present; security is not waived. The generic FAIL-only rule, expiry, organizational title, and concrete due-date fields are unmet or unspecified, so validation warns while honoring the explicit user-directed WAIVED outcome. |
| Final non-prescriptive/documentation checks | PASS | Artifacts remain readable/extensible, describe outcomes, and make WAIVED prominent without claiming PASS or Claude acceptance. |

## Deterministic Validation Probes

- Markdown matrix: 192 canonical FULL rows; `P0=150`, `P1=42`; no gap class or blocked mapped test.
- Principal evidence: 245 active declarations across 45 files; 0 skipped, pending, or fixme.
- Broader inventory: 67 files, 815 static declarations, 378 negative/edge signals.
- Machine outputs: valid JSON; source HEAD `59986a81bf3d9523d6a963b5891437bdb796e0ff`; candidate
  `c7753aa4829c758964a1c6811fc05b8d06aad4cd`; matching product/test, evidence, and package hashes.
- Exact-final retained result: 140/140 files and 1,944/1,944 tests PASS; static/build/audit/package/source-free/
  inertness facts remain unchanged.
- NFR disposition: 17 PASS / 0 CONCERNS / 0 FAIL / 1 WAIVED; NFR8 only; evidence gaps 1; blockers 0.
- External parity: 24 required, 0 executed, OAuth 401; no cell or behavioral acceptance inferred.
- Gate integrity: coverage `PASS`; integrated `WAIVED`; `human_disposition_recorded=true`;
  `human_disposition_required=false`; all final acceptance/publication/release/receiving-agent claims false.
- Output hygiene: no unresolved placeholder or stale final verdict; `git diff --check` clean.

## Waiver and Residual Risk

The user supplied the exact disposition `i allow it not to be the blocker, continue without it`. It applies to
NFR8 and the 24-cell authenticated Claude parity matrix. It removes the Phase-6 blocker but does not supply
evidence: Claude remains 0/24, parity remains unproven, and the final decision remains WAIVED rather than PASS.

If actual parity is required later, a human reauthenticates outside WPM, then an authorized executor uses a
fresh isolated environment and one newly accepted exact package, proves authentication with one canary, and
runs all 24 fresh subruns. No expiry or calendar due date was supplied for the waiver; neither is inferred.

## Validation Sign-Off

- **Phase-1 coverage validation:** PASS
- **Coverage gate:** PASS
- **NFR disposition:** WAIVED - 17 PASS / 0 CONCERNS / 0 FAIL / 1 WAIVED
- **Integrated Phase-6 gate:** WAIVED - HUMAN DISPOSITION RECORDED
- **Artifact validation:** PASS WITH WARNINGS
- **Open blockers:** 0
- **Claude behavioral acceptance:** Not claimed
- **Final PASS claimed:** No

The generic `_bmad-output/test-artifacts/trace-validation-report.md` belongs to unrelated EPIC-4
authoring-context work and was preserved unchanged. This report remains scoped to the complete initiative.

<!-- Powered by BMAD-CORE™ -->
